In tumours, the abnormal expression of the PI3K/Akt/mTOR pathway activates downstream signalling, such as the phosphorylation of 4E‐BP1, leading to the release of the eukaryotic translation initiation factor eIF4E and promoting protein translation [93]. The gene discussed is MTOR; the disease is neoplasm.